Medtronic plc has introduced its Beacon Heart Failure Management Service in the United States.

The new service operated through Medtronic Care Management Services (MCMS) combines data from the company’s implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices with post-acute monitoring from MCMS, enabling providers to focus on heart failure patients with the greatest risk and evaluate early intervention before a heart failure event occurs. 

Beacon integrates device diagnostics, analysis, and proprietary remote monitoring services from MCMS to generate an enhanced picture of a patient’s health. Patients using Beacon engage in daily health checks, which not only educate patients about their condition and self-care, but collect symptoms and biometrics through a series of branching-logic questions.

The data is assembled alongside diagnostics from the patient’s ICD or CRT device and reviewed by appropriately certified Medtronic care managers, who follow established clinical pathways to review incoming data, monitor for information that could indicate a growing risk of a heart failure event and alert providers accordingly.

Providers also receive monthly reports summarizing the patient’s health information. 

Medtronic plc, headquartered in Dublin, Ireland, employs more than 85,000 people worldwide and provides services to physicians, hospitals and patients in approximately 160 countries.